Pharmacokinetic evaluation of haemoperfusion in phenobarbital poisoning. 1984

D Jacobsen, and E Wiik-Larsen, and T Dahl, and E Enger, and P K Lunde

Charcoal haemoperfusion was performed for 5-12 h in three patients with maximal plasma phenobarbital concentrations of 600, 946 and 1044 mumol/l (138, 217 and 240 micrograms/ml). During haemoperfusion with constant blood flow phenobarbital elimination followed first order kinetics with half-lives of 11.1, 10.0 and 7.2 h, respectively. After termination of the haemoperfusion there was no rebound effect in plasma phenobarbital concentration and the elimination was first order with half-lives of 51, 82 and 48 h, respectively. Thus, the plasma phenobarbital half-life was reduced by 78-88% during haemoperfusion. In the same period 76-86% of the total body clearance of phenobarbital was due to the haemoperfusion column at a calculated volume of distribution of phenobarbital of 1.1-1.21/kg. This is clear evidence for recommending haemoperfusion in cases of serious poisoning with phenobarbital.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D010634 Phenobarbital A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations. Phenemal,Phenobarbitone,Phenylbarbital,Gardenal,Hysteps,Luminal,Phenobarbital Sodium,Phenobarbital, Monosodium Salt,Phenylethylbarbituric Acid,Acid, Phenylethylbarbituric,Monosodium Salt Phenobarbital,Sodium, Phenobarbital
D005260 Female Females
D006464 Hemoperfusion Removal of toxins or metabolites from the circulation by the passing of blood, within a suitable extracorporeal circuit, over semipermeable microcapsules containing adsorbents (e.g., activated charcoal) or enzymes, other enzyme preparations (e.g., gel-entrapped microsomes, membrane-free enzymes bound to artificial carriers), or other adsorbents (e.g., various resins, albumin-conjugated agarose). Hemosorption,Hemoperfusions,Hemosorptions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

D Jacobsen, and E Wiik-Larsen, and T Dahl, and E Enger, and P K Lunde
November 2011, British journal of anaesthesia,
D Jacobsen, and E Wiik-Larsen, and T Dahl, and E Enger, and P K Lunde
January 1980, Archives of toxicology,
D Jacobsen, and E Wiik-Larsen, and T Dahl, and E Enger, and P K Lunde
July 1985, British medical journal (Clinical research ed.),
D Jacobsen, and E Wiik-Larsen, and T Dahl, and E Enger, and P K Lunde
July 1983, Lancet (London, England),
D Jacobsen, and E Wiik-Larsen, and T Dahl, and E Enger, and P K Lunde
November 1990, The International journal of artificial organs,
D Jacobsen, and E Wiik-Larsen, and T Dahl, and E Enger, and P K Lunde
January 1981, Human toxicology,
D Jacobsen, and E Wiik-Larsen, and T Dahl, and E Enger, and P K Lunde
December 1995, Journal of tropical pediatrics,
D Jacobsen, and E Wiik-Larsen, and T Dahl, and E Enger, and P K Lunde
February 1978, Lancet (London, England),
D Jacobsen, and E Wiik-Larsen, and T Dahl, and E Enger, and P K Lunde
January 1980, Lancet (London, England),
D Jacobsen, and E Wiik-Larsen, and T Dahl, and E Enger, and P K Lunde
January 1980, Lancet (London, England),
Copied contents to your clipboard!